Biodegradable-Polymer or Durable-Polymer Stents in Patients at High Bleeding Risk: A Randomized, Open-Label Clinical Trial

Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents

(2022) David E. Kandzari et al.   JACC-Cardiovascular Interventions

3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation

(2021) Roxana Mehran et al.   JACC-Cardiovascular Interventions

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk

(2021) Marco Valgimigli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk

(2020) Stephan Windecker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk

(2020) Noé Corpataux et al.   EUROPEAN HEART JOURNAL

Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI

(2020) Davide Capodanno et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Target Lesion Failure With Current Drug-Eluting Stents

(2020) Nevio Taglieri et al.   JACC-Cardiovascular Interventions

Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk

(2019) Philip Urban et al.   EUROPEAN HEART JOURNAL

Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document

(2018) Hector M. Garcia-Garcia et al.   CIRCULATION

Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial

(2018) Olivier Varenne et al.   LANCET

Fourth universal definition of myocardial infarction (2018)

(2018) Kristian Thygesen et al.   EUROPEAN HEART JOURNAL

Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials

(2017) Francesco Costa et al.   LANCET

Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?

(2016) Sara Ariotti et al.   JACC-Cardiovascular Interventions

Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates

(2015) Marco Valgimigli et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk

(2015) Philip Urban et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial

(2014) Thomas Pilgrim et al.   LANCET

Consideration of a New Definition of Clinically Relevant Myocardial Infarction After Coronary Revascularization

(2013) Issam D. Moussa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Third universal definition of myocardial infarction

(2012) Kristian Thygesen et al.   EUROPEAN HEART JOURNAL

Standardized Bleeding Definitions for Cardiovascular Clinical Trials

(2011) Roxana Mehran et al.   CIRCULATION

Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity

(2010) Pascal Vranckx et al.   EuroIntervention

Cardiogenic Shock

(2008) Harmony R. Reynolds et al.   CIRCULATION